127 related articles for article (PubMed ID: 35031090)
1. The Optimal Sample Size for Usability Testing, From the Manufacturer's Perspective: A Value-of-Information Approach.
Caron A; Vandewalle V; Marcilly R; Rochat J; Dervaux B
Value Health; 2022 Jan; 25(1):116-124. PubMed ID: 35031090
[TBL] [Abstract][Full Text] [Related]
2. Optimal sample size determinations from an industry perspective based on the expected value of information.
Willan AR
Clin Trials; 2008; 5(6):587-94. PubMed ID: 19029207
[TBL] [Abstract][Full Text] [Related]
3. Globally optimal trial design for local decision making.
Eckermann S; Willan AR
Health Econ; 2009 Feb; 18(2):203-16. PubMed ID: 18435429
[TBL] [Abstract][Full Text] [Related]
4. Estimating the number of usability problems affecting medical devices: modelling the discovery matrix.
Vandewalle V; Caron A; Delettrez C; Périchon R; Pelayo S; Duhamel A; Dervaux B
BMC Med Res Methodol; 2020 Sep; 20(1):234. PubMed ID: 32948143
[TBL] [Abstract][Full Text] [Related]
5. Risk-based, 6-monthly and 24-monthly dental check-ups for adults: the INTERVAL three-arm RCT.
Clarkson JE; Pitts NB; Goulao B; Boyers D; Ramsay CR; Floate R; Braid HJ; Fee PA; Ord FS; Worthington HV; van der Pol M; Young L; Freeman R; Gouick J; Humphris GM; Mitchell FE; McDonald AM; Norrie JD; Sim K; Douglas G; Ricketts D
Health Technol Assess; 2020 Nov; 24(60):1-138. PubMed ID: 33215986
[TBL] [Abstract][Full Text] [Related]
6. The value of value of information: best informing research design and prioritization using current methods.
Eckermann S; Karnon J; Willan AR
Pharmacoeconomics; 2010; 28(9):699-709. PubMed ID: 20629473
[TBL] [Abstract][Full Text] [Related]
7. Value of Information Analytical Methods: Report 2 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force.
Rothery C; Strong M; Koffijberg HE; Basu A; Ghabri S; Knies S; Murray JF; Sanders Schmidler GD; Steuten L; Fenwick E
Value Health; 2020 Mar; 23(3):277-286. PubMed ID: 32197720
[TBL] [Abstract][Full Text] [Related]
8. Expected value of information and decision making in HTA.
Eckermann S; Willan AR
Health Econ; 2007 Feb; 16(2):195-209. PubMed ID: 16981193
[TBL] [Abstract][Full Text] [Related]
9. Optimal Allocation of Research Funds under a Budget Constraint.
Fairley M; Cipriano LE; Goldhaber-Fiebert JD
Med Decis Making; 2020 Aug; 40(6):797-814. PubMed ID: 32845233
[No Abstract] [Full Text] [Related]
10. Value of research and value of development in early assessments of new medical technologies.
Retèl VP; Grutters JP; van Harten WH; Joore MA
Value Health; 2013; 16(5):720-8. PubMed ID: 23947964
[TBL] [Abstract][Full Text] [Related]
11. Value of information analysis optimizing future trial design from a pilot study on catheter securement devices.
Tuffaha HW; Reynolds H; Gordon LG; Rickard CM; Scuffham PA
Clin Trials; 2014 Dec; 11(6):648-56. PubMed ID: 25084784
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic management strategies for adults and children with minor head injury: a systematic review and an economic evaluation.
Pandor A; Goodacre S; Harnan S; Holmes M; Pickering A; Fitzgerald P; Rees A; Stevenson M
Health Technol Assess; 2011 Aug; 15(27):1-202. PubMed ID: 21806873
[TBL] [Abstract][Full Text] [Related]
13. Determining optimal sample sizes for multistage adaptive randomized clinical trials from an industry perspective using value of information methods.
Chen MH; Willan AR
Clin Trials; 2013 Feb; 10(1):54-62. PubMed ID: 23263520
[TBL] [Abstract][Full Text] [Related]
14. "Stick or Twist?" Negotiating Price and Data in an Era of Conditional Approval.
Gladwell D; Bullement A; Cowell W; Patterson K; Strong M
Value Health; 2020 Feb; 23(2):191-199. PubMed ID: 32113624
[TBL] [Abstract][Full Text] [Related]
15. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
[TBL] [Abstract][Full Text] [Related]
16. A new approach for sample size calculation in cost-effectiveness studies based on value of information.
Bader C; Cossin S; Maillard A; Bénard A
BMC Med Res Methodol; 2018 Oct; 18(1):113. PubMed ID: 30348087
[TBL] [Abstract][Full Text] [Related]
17. Detectability of use errors in summative usability tests of medical devices: Impact of the test environment.
Marcilly R; Schiro J; Genin M; Somers S; Migaud MC; Mabile F; Pelayo S; Del Zotto M; Rochat J
Appl Ergon; 2024 Jul; 118():104266. PubMed ID: 38479216
[TBL] [Abstract][Full Text] [Related]
18. Complementing the net benefit approach: a new framework for Bayesian cost-effectiveness analysis.
Hernández MA; Vázquez-Polo FJ; González-Torre FJ; Bas EM
Int J Technol Assess Health Care; 2009 Oct; 25(4):537-45. PubMed ID: 19845984
[TBL] [Abstract][Full Text] [Related]
19. When is enough evidence enough? - Using systematic decision analysis and value-of-information analysis to determine the need for further evidence.
Siebert U; Rochau U; Claxton K
Z Evid Fortbild Qual Gesundhwes; 2013; 107(9-10):575-84. PubMed ID: 24315327
[TBL] [Abstract][Full Text] [Related]
20. Using value of information methods to determine the optimal sample size for effectiveness trials of alcohol interventions for HIV-infected patients in East Africa.
Li L; Uyei J; Nucifora KA; Kessler J; Stevens ER; Bryant K; Braithwaite RS
BMC Health Serv Res; 2018 Jul; 18(1):590. PubMed ID: 30064428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]